Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

UBS, China Life asset management venture plan in limbo as talks stall - sources

Published 03/24/2022, 06:38 AM
Updated 03/24/2022, 06:41 AM
© Reuters. FILE PHOTO: The logo of Swiss bank UBS is seen in Zurich, Switzerland October 25, 2018. REUTERS/Arnd Wiegmann/File Photo

By Samuel Shen and Selena Li

SHANGHAI/HONG KONG (Reuters) - A plan by UBS and China Life Insurance Group to set up an asset management joint venture in China faces uncertainty as talks have stalled due to a corruption investigation at the insurer and curbs set on the scope of the business, two sources said.

China Life's asset management arm and the Swiss bank began negotiations in late 2020 to jointly form a so-called "wealth management company" to manage money for mainly retail investors, Reuters reported in December, citing sources.

The discussions have now stalled, though they have not been formally called off, said the sources, who had knowledge of the matter but declined to be identified as they were not authorised to speak to the media.

The stalling of the talks underscores challenges for western financial firms looking to expand and grab a bigger share of China's 100 trillion yuan ($15.70 trillion) asset management sector, which has opened up for bigger foreign participation.

The talks have cooled as the then Chairman of China Life Insurance Group, Wang Bin, was put under investigation by the country's corruption watchdog in January.

The development has resulted in a review of planned deals initiated under Wang's watch, said the sources.

The joint venture talks faded also because the scope of business for such asset management ventures was overestimated, said the sources.

UBS had originally hoped that the planned venture would be able to sell wealth management products (WMPs) via China Life's army of insurance agents - an idea that was later proven to be misplaced under new rules for selling of such products published last year.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The China Banking and Insurance Regulatory Commission (CBIRC) published rules in 2021 that stipulate only banks and other deposit-taking financial institutions are allowed to distribute WMPs.

UBS declined to comment, while a spokesperson for China Life Insurance Co Ltd, the listed arm of China Life Insurance Group, did not respond to Reuters' request for comment.

"We are still pushing, but the progress is behind our expectations," one of the sources told Reuters, referring to the status of joint venture discussions.

UBS was looking to hold a majority stake in the venture, permitted by China in such partnerships since 2019.

China in 2018 allowed banks and other eligible financial institutions to set up so-called "wealth management companies" - in essence asset management firms - as part of a campaign to squeeze risky shadow banking.

An ensuing push by Beijing to lure foreign investors into the space led to a flurry of deals by global asset managers, including BlackRock (NYSE:BLK), Amundi, Schroders (LON:SDR), and Goldman Sachs (NYSE:GS), to form majority-owned ventures with Chinese lenders.

($1 = 6.3677 Chinese yuan renminbi)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.